Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index
29 juil. 2024 08h30 HE
|
Carmell Corporation
Carmell Corp (Nasdaq: CTCX) announced the appointment of Kendra Bracken-Ferguson as CEO effective July 30, 2024 with Rajiv Shukla continuing as Chairman.
Carmell Announces Successful Closing of $3.0 Million Private Placement
11 avr. 2024 16h30 HE
|
Carmell Corporation
PITTSBURGH, April 11, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today...
Carmell Announces $3.0 Million Private Placement
04 avr. 2024 08h30 HE
|
Carmell Corporation
PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today...
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
27 mars 2024 09h15 HE
|
Carmell Corporation
PITTSBURGH, March 27, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today...
Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
20 mars 2024 16h39 HE
|
Carmell Corporation
Carmell today announced the execution of a definitive agreement to sell its wholly owned subsidiary Axolotl Biologix
Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field
18 mars 2024 15h16 HE
|
Carmell Corporation
Carmell to host an Investor Webinar titled “Unveiling the Secretome: On the Eve of Product Launch”